Literature DB >> 23352502

Global protein phosphorylation dynamics during deoxynivalenol-induced ribotoxic stress response in the macrophage.

Xiao Pan1, Douglas A Whitten, Ming Wu, Christina Chan, Curtis G Wilkerson, James J Pestka.   

Abstract

Deoxynivalenol (DON), a trichothecene mycotoxin produced by Fusarium that commonly contaminates food, is capable of activating mononuclear phagocytes of the innate immune system via a process termed the ribotoxic stress response (RSR). To encapture global signaling events mediating RSR, we quantified the early temporal (≤30min) phosphoproteome changes that occurred in RAW 264.7 murine macrophage during exposure to a toxicologically relevant concentration of DON (250ng/mL). Large-scale phosphoproteomic analysis employing stable isotope labeling of amino acids in cell culture (SILAC) in conjunction with titanium dioxide chromatography revealed that DON significantly upregulated or downregulated phosphorylation of 188 proteins at both known and yet-to-be functionally characterized phosphosites. DON-induced RSR is extremely complex and goes far beyond its prior known capacity to inhibit translation and activate MAPKs. Transcriptional regulation was the main target during early DON-induced RSR, covering over 20% of the altered phosphoproteins as indicated by Gene Ontology annotation and including transcription factors/cofactors and epigenetic modulators. Other biological processes impacted included cell cycle, RNA processing, translation, ribosome biogenesis, monocyte differentiation and cytoskeleton organization. Some of these processes could be mediated by signaling networks involving MAPK-, NFκB-, AKT- and AMPK-linked pathways. Fuzzy c-means clustering revealed that DON-regulated phosphosites could be discretely classified with regard to the kinetics of phosphorylation/dephosphorylation. The cellular response networks identified provide a template for further exploration of the mechanisms of trichothecenemycotoxins and other ribotoxins, and ultimately, could contribute to improved mechanism-based human health risk assessment.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23352502      PMCID: PMC4041276          DOI: 10.1016/j.taap.2013.01.007

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  79 in total

1.  Selective and antagonistic functions of SWI/SNF and Mi-2beta nucleosome remodeling complexes during an inflammatory response.

Authors:  Vladimir R Ramirez-Carrozzi; Aaron A Nazarian; Caiyi C Li; Sarah L Gore; Rupa Sridharan; Anthony N Imbalzano; Stephen T Smale
Journal:  Genes Dev       Date:  2006-02-01       Impact factor: 11.361

2.  Proteomic analysis of the effects of the immunomodulatory mycotoxin deoxynivalenol.

Authors:  André Nogueira da Costa; Renée S Mijal; Jeffrey N Keen; John B C Findlay; Christopher P Wild
Journal:  Proteomics       Date:  2011-04-04       Impact factor: 3.984

Review 3.  Cancer-preventive anti-oxidants that attenuate free radical generation by inflammatory cells.

Authors:  Akira Murakami; Hajime Ohigashi
Journal:  Biol Chem       Date:  2006-04       Impact factor: 3.915

Review 4.  The role of SHIP1 in macrophage programming and activation.

Authors:  M J Rauh; L M Sly; J Kalesnikoff; M R Hughes; L-P Cao; V Lam; G Krystal
Journal:  Biochem Soc Trans       Date:  2004-11       Impact factor: 5.407

5.  Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.

Authors:  Jesper V Olsen; Blagoy Blagoev; Florian Gnad; Boris Macek; Chanchal Kumar; Peter Mortensen; Matthias Mann
Journal:  Cell       Date:  2006-11-03       Impact factor: 41.582

Review 6.  Toxicity testing in the 21st century: bringing the vision to life.

Authors:  Melvin E Andersen; Daniel Krewski
Journal:  Toxicol Sci       Date:  2008-12-12       Impact factor: 4.849

7.  ZAK: a MAP3Kinase that transduces Shiga toxin- and ricin-induced proinflammatory cytokine expression.

Authors:  Dakshina M Jandhyala; Amrita Ahluwalia; Tom Obrig; Cheleste M Thorpe
Journal:  Cell Microbiol       Date:  2008-03-10       Impact factor: 3.715

8.  Tissue distribution and proinflammatory cytokine gene expression following acute oral exposure to deoxynivalenol: comparison of weanling and adult mice.

Authors:  James J Pestka; Chidozie J Amuzie
Journal:  Food Chem Toxicol       Date:  2008-07-09       Impact factor: 6.023

9.  Deoxynivalenol induces p38 interaction with the ribosome in monocytes and macrophages.

Authors:  Hee Kyong Bae; James J Pestka
Journal:  Toxicol Sci       Date:  2008-05-22       Impact factor: 4.849

10.  Identification of a novel protein from glial cells based on its ability to interact with NF-kappaB subunits.

Authors:  Thersa Sweet; Kamel Khalili; Bassel E Sawaya; Shohreh Amini
Journal:  J Cell Biochem       Date:  2003-12-01       Impact factor: 4.429

View more
  11 in total

Review 1.  Mycotoxins: cytotoxicity and biotransformation in animal cells.

Authors:  Jikai Wen; Peiqiang Mu; Yiqun Deng
Journal:  Toxicol Res (Camb)       Date:  2016-01-07       Impact factor: 3.524

2.  Phosphoproteome and transcription factor activity profiling identify actions of the anti-inflammatory agent UTL-5g in LPS stimulated RAW 264.7 cells including disrupting actin remodeling and STAT-3 activation.

Authors:  Nicholas J Carruthers; Paul M Stemmer; Ben Chen; Frederick Valeriote; Xiaohua Gao; Subhash C Guatam; Jiajiu Shaw
Journal:  Eur J Pharmacol       Date:  2017-05-31       Impact factor: 4.432

3.  Dynamic changes in ribosome-associated proteome and phosphoproteome during deoxynivalenol-induced translation inhibition and ribotoxic stress.

Authors:  Xiao Pan; Douglas A Whitten; Curtis G Wilkerson; James J Pestka
Journal:  Toxicol Sci       Date:  2013-11-27       Impact factor: 4.849

4.  Early phosphoproteomic changes in the mouse spleen during deoxynivalenol-induced ribotoxic stress.

Authors:  Xiao Pan; Douglas A Whitten; Ming Wu; Christina Chan; Curtis G Wilkerson; James J Pestka
Journal:  Toxicol Sci       Date:  2013-06-29       Impact factor: 4.849

5.  TaFROG Encodes a Pooideae Orphan Protein That Interacts with SnRK1 and Enhances Resistance to the Mycotoxigenic Fungus Fusarium graminearum.

Authors:  Alexandre Perochon; Jia Jianguang; Amal Kahla; Chanemougasoundharam Arunachalam; Steven R Scofield; Sarah Bowden; Emma Wallington; Fiona M Doohan
Journal:  Plant Physiol       Date:  2015-10-27       Impact factor: 8.340

6.  Mercury alters B-cell protein phosphorylation profiles.

Authors:  Nicholas J Caruthers; Paul M Stemmer; Namhee Shin; Alan Dombkowski; Joseph A Caruso; Randal Gill; Allen Rosenspire
Journal:  J Proteome Res       Date:  2013-12-04       Impact factor: 4.466

7.  Exploring the dermotoxicity of the mycotoxin deoxynivalenol: combined morphologic and proteomic profiling of human epidermal cells reveals alteration of lipid biosynthesis machinery and membrane structural integrity relevant for skin barrier function.

Authors:  Giorgia Del Favero; Lukas Janker; Benjamin Neuditschko; Julia Hohenbichler; Endre Kiss; Lydia Woelflingseder; Christopher Gerner; Doris Marko
Journal:  Arch Toxicol       Date:  2021-04-23       Impact factor: 5.153

Review 8.  From the gut to the brain: journey and pathophysiological effects of the food-associated trichothecene mycotoxin deoxynivalenol.

Authors:  Marc Maresca
Journal:  Toxins (Basel)       Date:  2013-04-23       Impact factor: 4.546

9.  Phosphoproteome Analysis Reveals the Molecular Mechanisms Underlying Deoxynivalenol-Induced Intestinal Toxicity in IPEC-J2 Cells.

Authors:  Zhi-Qi Zhang; Song-Bo Wang; Rui-Guo Wang; Wei Zhang; Pei-Long Wang; Xiao-Ou Su
Journal:  Toxins (Basel)       Date:  2016-09-22       Impact factor: 4.546

10.  Minimal Concentrations of Deoxynivalenol Reduce Cytokine Production in Individual Lymphocyte Populations in Pigs.

Authors:  Karolina Hlavová; Hana Štěpánová; Kamil Šťastný; Lenka Levá; Nikola Hodkovicová; Monika Vícenová; Ján Matiašovic; Martin Faldyna
Journal:  Toxins (Basel)       Date:  2020-03-18       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.